Screener
BioMarin Pharmaceuticals BMRN Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest expense | (63,295) | (2,679) | (78,253) | (5,542) |
| Other income, net | 3,279 | 4,833 | 7,240 | 2,879 |
| INCOME BEFORE INCOME TAXES | 61,384 | 297,868 | 202,587 | 535,957 |
| Provision for income taxes | 16,622 | 57,336 | 52,298 | 109,739 |
| NET INCOME | $44,762 | $240,532 | $150,289 | $426,218 |
| EARNINGS PER SHARE, BASIC | $0.23 | $1.25 | $0.78 | $2.23 |
| EARNINGS PER SHARE, DILUTED | $0.23 | $1.23 | $0.77 | $2.19 |
| Weighted average common shares outstanding, basic | 193,423 | 191,907 | 192,959 | 191,440 |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's income tax?
- BioMarin Pharmaceuticals (BMRN) reported income tax of $16.62M in Q2 2026.
- How has BioMarin Pharmaceuticals's income tax changed year-over-year?
- BioMarin Pharmaceuticals's income tax decreased by 71.0% year-over-year, from $57.34M to $16.62M.
- What is the long-term trend for BioMarin Pharmaceuticals's income tax?
- Over 3 years (2021 to 2025), BioMarin Pharmaceuticals's income tax has grown at a 128.0% compound annual growth rate (CAGR), from -$11.27M to $133.58M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about BioMarin Pharmaceuticals's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude